Abstract
(Cell Reports 15, 1024–1036; May 3, 2016) In the originally published version of this article, the concentration of dual-SMAD inhibitors used was incorrectly reported in the Supplemental Experimental Procedures as “0.1 mM LDN193189 (Stemgent) and 10 mM SB431542 (Tocris)” instead of “0.1 μM LDN193189 (Stemgent) and 10 μM SB431542 (Tocris).” The Supplemental Experimental Procedures section has now been corrected online. The authors regret this error.
| Original language | English |
|---|---|
| Pages (from-to) | 2525 |
| Number of pages | 1 |
| Journal | Cell Reports |
| Volume | 20 |
| Issue number | 10 |
| DOIs |
|
| Publication status | Published - 5 Sep 2017 |
Fingerprint
Dive into the research topics of 'Erratum: Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells (Cell Reports (2016) 15(5) (1024–1036) (S2211124716303965) (10.1016/j.celrep.2016.03.090))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver